9:00 Tertiary Life Settlement Market

• Reviewing key considerations in the creation of a transferable asset
• Discussing the importance of maintenance and product value enhancement
• Highlighting regulatory concerns and exploring the transaction process
• Examining various methods for asset disposition and acquisition

Nate Evans
President and Chief Executive Officer
Maple Life Financial Inc.

Kathleen A. Birrane
Senior Vice President and General Counsel
Maple Life Financial Inc.

ILS Gone Bad

• Reviewing deals and securitizations that
• went bad and what they meant for the marketplace
• Acknowledging the risks inherent in CAT bonds and longevity swaps and becoming comfortable with them
• Investigating the impact of securitized risk transactions on the collapse of Lehman Brothers

Urs Ramseier
Head of Insurance Linked Securities
Horizon 21

Robert Herde, Ph.D.
Executive Director
Munich Re Capital Markets

9:50 Investing in Longevity Risk from Pensions and Life Settlements

• Outlining the parameters for offloading and investing in pension longevity risk
• Assessing the impact of a pure longevity risk market on the life settlements market
• Developing a portfolio of complementary longevity risks
• Responding to the data demands of large, long dated pools inherent to pension risks

Guy Coughlan
Global Head of Pension ALM
J.P. Morgan

Rohit Sharma
Executive Director, Life Finance Group
J.P. Morgan

John Fitzpatrick
Partner and Director
The Pension Corporation

The Next Frontier: Securitizing New Risks

• Searching for ways to transfer new risks through the capital markets
• Outlining investor and issuer demands in deal structures
• Detailing barriers for growth in new regions

Dirk Lohmann
CEO
Secquaero

Hilary Paul
Vice President and Fund Manager
Clariden Leu

Bill Dubinsky
Managing Director
Swiss Re

11:20 Reviewing the Regulatory Environment Surrounding Life Settlements

• Addressing the impact of stranger-owned life insurance policies in the US regulatory arena
• Reviewing legislation that regulates life settlements and STOLIs and their impact on the industry

Moderator:
Rachel Coan
Partner
Morrison & Foerster

Michael Freedman
Senior Vice President, Governmental Affairs
Coventry

Brian Casey
Partner
Lock Lord Bissell & Liddell

Rob Haynie
Managing Director
Life Insurance Settlements

Doug Head
Executive Director
Life Insurance Settlements Association

Investigating the Role of Governments and Regulators in Alternative Risk Transfer and Finance

• Understanding the insurance risk burdens and reinsurance dilemmas of state and national governments
• Outlining the capacity and solutions presented by the capital markets
• Addressing obstacles to state and federal catastrophe bond programs
• Reviewing regulatory and legislative developments in the U.S. and abroad
• Investing in catastrophe risk carried by governments in developing regions

Eugene Gurenko
Lead Insurance and Risk Management Specialist
World Bank

Simon Young
CEO
CaribRM

1:40 Implementing Actuarial Tools in Risk Management Analyses

• Understanding what longevity tables tell us and how the metrics are calculated
• Using actuarial tables to balance a portfolio of ILS and life settlements
• Addressing changes to the VBT tables and what these changes mean for life expectancy models

Vince Granieri
Chief Underwriter
21st Services

Managing a Portfolio of Insurance-Linked Securities

• Defining ideal trigger/peril combinations
• Exploring the mechanics of risk measurement and diversification techniques
• Establishing a benchmark for risk in a portfolio and identifying areas for improvement

Ben Rockmuller
CFA, Analyst
Oppenheimer Funds

Alex Krutov, FCAS, ASA, MAAA,
Managing Director
Century Atlantic Capital

Moderator:
Pascal Karsenti
Senior Risk Advisor
AIR Worldwide

2:30 Clinical Perspectives on Investment Risk for Life Settlement Portfolios

• Considering impairments linked to life settlements from a clinical perspective
• Understanding the need to diversify by impairment
• Analyzing variability in actual to expected ratios of different impairments
• Evaluating variations in life expectancy with relevance to the clinical setting

Mike Fasano
President
Fasano & Associates

Dr. David Vaughan
Vice President & Medical Director
Fasano & Associates

Arshad Hasan Qureshi
Actuary
Fasano & Associates

CAT Retrocession Market

• Examining drivers of the market
• Detailing market pricing and the role of capital markets
• Discovering what this market can tell us about the general reinsurance and ILS markets
• Future prospects for the CAT retrocession market

Lixin Zeng
Executive Risk Officer
Validus Re